Suppr超能文献

抗高血压药物的价值:医学创新视角

The value of antihypertensive drugs: a perspective on medical innovation.

作者信息

Cutler David M, Long Genia, Berndt Ernst R, Royer Jimmy, Fournier Andrée-Anne, Sasser Alicia, Cremieux Pierre

机构信息

Department of Economics, Harvard University, Cambridge, Massachusetts, USA.

出版信息

Health Aff (Millwood). 2007 Jan-Feb;26(1):97-110. doi: 10.1377/hlthaff.26.1.97.

Abstract

Using national survey data and risk equations from the Framingham Heart Study, we quantify the impact of antihypertensive therapy changes on blood pressures and the number and cost of heart attacks, strokes, and deaths. Antihypertensive therapy has had a major impact on health. Without it, 1999-2000 average blood pressures (at age 40+) would have been 10-13 percent higher, and 86,000 excess premature deaths from cardiovascular disease would have occurred in 2001. Treatment has generated a benefit-to-cost ratio of at least 6:1, but much more can be achieved. More effective use of antihypertensive medication would have an impact on mortality akin to eliminating all deaths from medical errors or accidents.

摘要

利用全国性调查数据以及弗雷明汉心脏研究的风险方程,我们对降压治疗变化对血压、心脏病发作、中风及死亡的数量和成本的影响进行了量化。降压治疗对健康产生了重大影响。若没有降压治疗,1999 - 2000年(40岁及以上人群)的平均血压会高出10% - 13%,2001年将会有86,000例因心血管疾病导致的额外过早死亡。治疗产生的效益成本比至少为6:1,但仍有很大提升空间。更有效地使用降压药物对死亡率的影响相当于消除所有因医疗差错或事故导致的死亡。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验